2017年乌克兰儿童乙型肝炎病毒感染标志物血清流行率调查
2017年在乌克兰四个地区对2006-2015年出生儿童开展血清学调查,共检测4596名儿童,抗-HBc阳性率为1.8%,HBsAg阳性率为0.2%;调查地区儿童HBV流行率较低,但乙型肝炎疫苗接种覆盖率不理想,2009年后出生儿童尤其明显。
要点
- 调查地区儿童HBsAg总阳性率为0.2%,仅Zakarpattya省(0.7%)超过欧洲区域0.5%的目标。
- 2006-2009年出生队列中≥3剂HepB接种比例为53%-80%,2010-2015年队列降至28%-59%。
- 应提高HepB覆盖率以进一步减少儿童HBV传播并实现区域和全球控制/消除目标。
核心结论
- 2017年乌克兰调查地区儿童HBV流行率较低,但HepB接种不理想,大量儿童未接种或接种不全,面临未来HBV感染风险。
研究设计与样本
- 2017年在乌克兰Zakarpattya、Sumy、Odessa三省和Kyiv市开展血清学调查,目标人群为2006-2015年出生队列。
- 省份采用一阶段整群抽样,Kyiv市采用分层简单随机抽样,共检测4596名儿童。
- 所有参与者检测抗-HBc,抗-HBc阳性者检测HBsAg,并获取所有儿童的HepB接种状态信息。
主要发现
- 4596名受检儿童中,81名(1.8%)抗-HBc阳性,8名(0.2%)HBsAg阳性。
- HBsAg阳性率:Zakarpattya 0.7%(95%CI 0.3%-1.4%),Sumy 0.1%(95%CI 0.0%-0.4%),Odessa 0%(95%CI 0.0%-0.3%),Kyiv 0.1%(95%CI 0.0%-0.8%)。
- 各调查点≥3剂HepB接种比例:2006-2009年出生队列为53%-80%,2010-2015年出生队列为28%-59%。
临床怎么用
- 应提高HepB覆盖率,尤其关注2009年后出生儿童,以减少未接种或接种不全儿童的未来HBV感染风险。
- Zakarpattya省HBsAg血清流行率超过欧洲区域0.5%的目标,需重点加强防控。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Before hepatitis B vaccine (HepB) introduction, level of endemicity of hepatitis B virus (HBV) in Ukraine was estimated as intermediate but the prevalence of HBV infection markers has not been measured in population-based serosurveys. Coverage with 3 doses of HepB, introduced in 2002, was 92%-98% during 2004-2007 but declined to 21%-48% during 2010-2016. To obtain data on HBV prevalence among children born after HepB introduction, we tested specimens from a serosurvey conducted in Ukraine in 2017, following circulating vaccine-derived poliovirus outbreak in 2015, among birth cohorts eligible for polio immunization response. METHODS: The serosurvey was conducted in Zakarpattya, Sumy, and Odessa provinces, and Kyiv City, targeting 2006-2015 birth cohorts. One-stage cluster sampling in the provinces and stratified simple random sampling in Kyiv were used for participant selection. All participants were tested for antibodies against HBV core antigen (anti-HBc). Anti-HBc-positive children were tested for HBV surface antigen (HBsAg). We also obtained information on HepB vaccination status for all children. RESULTS: Of 4,596 children tested, 81 (1.8%) were anti-HBc-positive and eight (0.2%) were HBsAg-positive. HBsAg prevalence was 0.7% (95% confidence interval, 0.3%-1.4%) in Zakarpattya, 0.1% (0.0%-0.4%) in Sumy, 0% (0.0%-03%) in Odessa, and 0.1% (0.0%-0.8%) in Kyiv. Across survey sites, the proportion of recipients of ≥ 3 HepB doses was 53%-80% in the 2006-2009 cohort and 28%-59% in the 2010-2015 cohort. CONCLUSION: HBV prevalence among children in surveyed regions of Ukraine in 2017 was low, including in Zakarpattya-the only site above the 0.5% European Regional target for HBsAg seroprevalence. However, HepB vaccination was suboptimal, particularly among children born after 2009, resulting in large numbers of unvaccinated or incompletely vaccinated children at risk of future HBV infection. HepB coverage should be increased to further reduce HBV transmission among children in Ukraine and achieve regional and global hepatitis B control/elimination targets.
引用
- Khetsuriani N, Zaika O, Chitadze N, et al. Seroprevalence of hepatitis B virus infection markers among children in Ukraine, 2017. Vaccine. 2021. PMID: 33583671. doi:10.1016/j.vaccine.2021.02.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。